FDA endorses 2d firm on silicone implant sales
Inamed gave agency more safety data after its rejection in April
The Food and Drug Administration yesterday told a second manufacturer it is willing to approve wider sales of its silicone gel-filled breast implants, which are expected to return to the US market by year's end. (Full article: 532 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
